Cargando…
Gold(III)–pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents**
Transition metals offer many possibilities in developing potent chemotherapeutic agents. They are endowed with a variety of oxidation states, allowing for the selection of their coordination numbers and geometries via the choice of proper ligands, leading to the tuning of their final biological prop...
Autores principales: | Nardon, Chiara, Chiara, Federica, Brustolin, Leonardo, Gambalunga, Alberto, Ciscato, Francesco, Rasola, Andrea, Trevisan, Andrea, Fregona, Dolores |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420591/ https://www.ncbi.nlm.nih.gov/pubmed/25969817 http://dx.doi.org/10.1002/open.201402091 |
Ejemplares similares
-
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells
por: Dalla Pozza, Maria, et al.
Publicado: (2021) -
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia
por: Nardon, Chiara, et al.
Publicado: (2014) -
Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell death
por: Chiara, F, et al.
Publicado: (2012) -
Reliability of Urinary Excretion Rate Adjustment in Measurements of Hippuric Acid in Urine
por: Nicolli, Annamaria, et al.
Publicado: (2014) -
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD(+) and SIRT3
por: Masgras, Ionica, et al.
Publicado: (2022)